Clinical Trial Update: Serum YKL-40 Level and Platelets Indices Among Patients With Diabetic Erectile Dysfunction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial examining serum YKL-40 levels and platelet indices in patients with diabetic erectile dysfunction, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus-related Erectile Dysfunction
• Erectile Dysfunction

Snippet

Sponsor: Aswan University | Conditions: Erectile Dysfunction, Erectile Dysfunction With Diabetes Mellitus | Phase 4 | Status: COMPLETED